Serum concentrations of CCL-18 and IL-23 in COPD patients are higher than that in healthy people and the increase of serum CCL-18 and IL-23 correlates with clinical stage of COPD. The gene discussed is IL37; the disease is chronic obstructive pulmonary disease.